ZURICH, Aug 21 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent lower at 8,857 points on Monday, according to premarket indications by bank Julius Baer .
The following are some of the main factors expected to affect Swiss stocks:
The Swiss bank said it has agreed to buy a roughly 2 billion Swiss franc ($2.1 billion) portfolio of eastern European private banking clients from Notenstein La Roche Private Bank Ltd.
For more click
Chief Executive Lukas Braunschweiler said his company’s new wireless hearing aid microchip that allows for direct streaming from mobile devices “will keep us competitive for the next six or seven years,” according to an interview that appeared Saturday in Finanz und Wirtschaft.
For more click
* Dufry said HNA now holds a total purchase position of 20.92 percent of Dufry shares, including a 16.2 percent stake previously held by GIC and Temasek. Dufry and HNA are now in talks over ways to boost revenue from Chinese travelers.
* Metall Zug said first-half net income rose 41.4 percent to 33.8 million francs. Operating income for the full year will be slightly lower than the 94 million francs of the previous year, it said.
* Novartis said it has combined with Medicines for Malaria to launch a patient trial for KAF156, a antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite.
SNB announces latest sight deposits at 0800 GMT (Reporting by Zurich newsroom)